Literature DB >> 24317853

Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment.

Hang Wun Raymond Li1, Vivian Chi Yan Lee, Pak Chung Ho, Ernest Hung Yu Ng.   

Abstract

PURPOSE: To validate the use of the ovarian sensitivity index (OSI) as a measure of ovarian response during in-vitro fertilization (IVF) treatment.
METHODS: This is a retrospective study carried out in an assisted reproduction unit in a teaching hospital. We analysed data from 2,556 women undergoing the first IVF cycle between 2002 and 2009. OSI was calculated as the number of retrieved oocytes divided by total dose of FSH administered (per 1,000 IU). Its correlation to other parameters of ovarian response was compared to that of the oocyte number.
RESULTS: The correlation coefficients of OSI with age, AFC, AMH, total dose of gonadotrophin, average daily dose of gonadotrophin and duration of stimulation were significantly higher than that of oocyte number with these respective parameters. OSI demonstrated a higher intraclass correlation coefficient (ICC) than the oocyte number when comparing the two parameters across the first and second stimulated IVF cycles.
CONCLUSIONS: OSI is a better measure of ovarian responsiveness to gonadotrophin stimulation than the oocyte number, and is particularly useful when different subjects are treated with different stimulation regimens which would have confounding effect on the oocyte number.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24317853      PMCID: PMC3933607          DOI: 10.1007/s10815-013-0144-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  10 in total

Review 1.  AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis.

Authors:  S L Broer; M Dólleman; B C Opmeer; B C Fauser; B W Mol; F J M Broekmans
Journal:  Hum Reprod Update       Date:  2010-07-28       Impact factor: 15.610

Review 2.  Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment.

Authors:  Ernest Hung Yu Ng
Journal:  Gynecol Endocrinol       Date:  2009-01       Impact factor: 2.260

3.  A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.

Authors:  K Jayaprakasan; J Hopkisson; B Campbell; I Johnson; J Thornton; N Raine-Fenning
Journal:  BJOG       Date:  2010-03-29       Impact factor: 6.531

4.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

Review 5.  Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS.

Authors:  Annick Delvigne
Journal:  Reprod Biomed Online       Date:  2009-07       Impact factor: 3.828

6.  A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment.

Authors:  Peter Y K Yong; Sandra Brett; David T Baird; K J Thong
Journal:  Fertil Steril       Date:  2003-02       Impact factor: 7.329

Review 7.  The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

Authors:  Simone L Broer; Ben Willem J Mol; Dave Hendriks; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2008-03-05       Impact factor: 7.329

8.  Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF.

Authors:  Valentina Biasoni; Ambra Patriarca; Paola Dalmasso; Angela Bertagna; Chiara Manieri; Chiara Benedetto; Alberto Revelli
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

9.  Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.

Authors:  Antonio La Marca; Valentina Grisendi; Simone Giulini; Cindy Argento; Alessandra Tirelli; Giulia Dondi; Enrico Papaleo; Annibale Volpe
Journal:  J Ovarian Res       Date:  2013-02-06       Impact factor: 4.234

10.  Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  10 in total
  12 in total

1.  Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.

Authors:  Philippe Merviel; Michel Menard; Rosalie Cabry; Florence Scheffler; Emmanuelle Lourdel; Marie-Thérèse Le Martelot; Sylvie Roche; Jean-Jacques Chabaud; Henri Copin; Hortense Drapier; Moncef Benkhalifa; Damien Beauvillard
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

2.  Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles.

Authors:  AbdelGany M A Hassan; Mohamed M M Kotb; Ahmed M A AwadAllah; Nesreen A A Shehata; Amr Wahba
Journal:  J Assist Reprod Genet       Date:  2017-07-03       Impact factor: 3.412

3.  Are ovarian responses and the number of transferable embryos different in females and partners of male balanced translocation carriers?

Authors:  Mingyue Liu; Zhiqin Bu; Yan Liu; Jinhao Liu; Shanjun Dai
Journal:  J Assist Reprod Genet       Date:  2022-08-04       Impact factor: 3.357

4.  Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?

Authors:  Sara Cesarano; Paul Pirtea; Achraf Benammar; Dominique De Ziegler; Marine Poulain; Alberto Revelli; Chiara Benedetto; Alexandre Vallée; Jean Marc Ayoubi
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

5.  Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.

Authors:  H R Nejabati; A Mota; L Farzadi; M Ghojazadeh; A Fattahi; K Hamdi; M Nouri
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

6.  Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

7.  Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Michela Quaranta; Federica Esposito; Decio Armanini; Michele Gangemi; Giovanni B Nardelli; Pietro Litta; Donato D'Antona; Guido Ambrosini
Journal:  Reprod Biol Endocrinol       Date:  2015-04-10       Impact factor: 5.211

8.  Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial.

Authors:  Joaquín Llácer; Belén Moliner; Lydia Luque; Andrea Bernabéu; Belén Lledó; Juan Carlos Castillo; Jaime Guerrero; Jorge Ten; Rafael Bernabéu
Journal:  Reprod Biol Endocrinol       Date:  2020-02-07       Impact factor: 5.211

9.  Comparison of ovarian responsiveness tests with outcome of assisted reproductive technology - a retrospective analysis.

Authors:  Selcuk Selcuk; Bulent Emre Bilgic; Cetin Kilicci; Mehmet Kucukbas; Cetin Cam; Huseyin Tayfun Kutlu; Ates Karateke
Journal:  Arch Med Sci       Date:  2016-09-22       Impact factor: 3.318

10.  Ovarian Sensitivity Index (OSI): Validating the Use of a Marker for Ovarian Responsiveness in IVF.

Authors:  Vikas Yadav; Neena Malhotra; Reeta Mahey; Neeta Singh; Alka Kriplani
Journal:  J Reprod Infertil       Date:  2019 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.